Sweden· SE-20190109000057
Vyndaqel 61 mg Kapsel, mjuk
A medicinal product containing tafamidis, registered in Sweden by Pfizer Europe MA EEIG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Tafamidis
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20190109000057
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tafamidis in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainTAFAMIDIS ACCORD 61 MG CAPSULAS BLANDAS EFGAccord Healthcare S.L.U.
- BelgiumTafamidis EG 61 mgEG
- IrelandVyndaqel 61 mg soft capsulesPfizer Europe MA EEIG
- CzechiaVYNDAQELPfizer Europe MA EEIG, Bruxelles
- FranceVYNDAQEL 61 mg, capsule mollePFIZER EUROPE MA EEIG (BELGIQUE)
- IcelandVyndaqelPfizer Europe MA EEIG*
- NorwayVyndaqelPfizer Europe MA EEIG (1)
- PolandVyndaqelPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Tafamidis Stada, Tafamidis Viatris
- Belgium · Tafamidis Viatris
- Germany · Tafamidis Al, Tafamidis Viatris
- Spain · Tafamidis Stada, Tafamidis Viatris
- France · Tafamidis Biogaran, Tafamidis Eg
- United Kingdom (Northern Ireland) · Tafamidis Thornton & Ross
- Iceland · Vyndaqel
- Liechtenstein · Vyndaqel
- Norway · Tafamidis Stada Nordic, Tafamidis Viatris
- Slovenia · Tafamidis Sumar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/add25ab7-10ac-4a84-9d05-ecbd0d94ec8c GET /v1/drugs/add25ab7-10ac-4a84-9d05-ecbd0d94ec8c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20190109000057",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190109000057",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/vyndaqel-epar-product-information_sv.pdf"
}See everything about tafamidis.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.